Cleveland BioLabs Inc. (CBLI) Fell -5.57% or -0.16 To Price $2.76 On Wednesday


Cleveland BioLabs Inc. (CBLI) fell -5.57% or -0.16 to $2.76. It is near to 18416 shares traded, which is 143.65% compare to the average total volume 12820. The market cap of CBLI is $31.18 million. The year to date change is -24.28%. The 52 week price range is from $2.24 to $4.36. Price of CBLI have changed 5.00% during last week. It have changed 1.48% over last month, -18.59% over last 3 months, 12.41% over last 6 months and -20.14% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBLI is 2.94. It is 6.52% above current price. The 200-day Moving Averages for CBLI is 3.14. It is 13.77% above current price. The 52-week High is 4.36. It is 57.97% from the current price. The 52-week Low is 2.24. It is -18.84% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CBLI is 1.4 on 2018-05-15. Short % to float is 0.28%. There are some statistics of CBLI. It is has market cap $31.18 million. The share outstanding is 11.30 million. The average volume is 12820. The percent of top 15 Institution holding is 5.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBLI is -234.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBLI is -75.86%.


Tags:

Share this post